SKI Market

A+| A| A-|

Indian Indices

Sensex

76,009.70 -479.26
( -0.63%)

Global Indices

Nasdaq

50,600.70 294.03
(0.58%)

Dow Jones

7,494.47 27.75
(0.37%)

Hang Seng

64,932.04 -226.15
(-0.35%)

Nikkei 225

10,466.26 22.79
(0.22%)

Forex

USD-INR

95.61 -0.67
(-0.70%)

EUR-INR

110.97 -0.85
(-0.76%)

GBP-INR

128.43 -0.86
(-0.66%)

JPY-INR

0.60 0.00
(-0.79%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

78871

INE0L4V01013

17.34

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VILINBIO

317.33

72.59

EPS(TTM)

Face Value()

Div & Yield %

0.15

Back

GSM Foils standalone net profit rises 95.96% in the December 2025 quarter

Feb 14,2026

Net profit of GSM Foils rose 95.96% to Rs 5.33 crore in the quarter ended December 2025 as against Rs 2.72 crore during the previous quarter ended December 2024. Sales rose 84.15% to Rs 66.33 crore in the quarter ended December 2025 as against Rs 36.02 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	66.33	36.02	84
OPM %	11.88	11.24	-
PBDT	7.23	3.85	88
PBT	7.12	3.77	89
NP	5.33	2.72	96

76,009.70 -479.26 ( -0.63%)

50,600.70 294.03 (0.58%)

7,494.47 27.75 (0.37%)

64,932.04 -226.15 (-0.35%)

10,466.26 22.79 (0.22%)

95.61 -0.67 (-0.70%)

110.97 -0.85 (-0.76%)

128.43 -0.86 (-0.66%)

0.60 0.00 (-0.79%)